Therapeutic activity of humanized anti-CD20 monoclonal antibody and polymorphism in IgG Fc receptor FcγRIIIa gene
Top Cited Papers
Open Access
- 1 February 2002
- journal article
- clinical trial
- Published by American Society of Hematology in Blood
- Vol. 99 (3), 754-758
- https://doi.org/10.1182/blood.v99.3.754
Abstract
Given that the FcγRIIIa receptor 158V allotype displays a higher affinity for human immunoglobulin G1 and increased antibody-dependent cellular cytotKeywords
This publication has 32 references indexed in Scilit:
- High Resolution Mapping of the Binding Site on Human IgG1 for FcγRI, FcγRII, FcγRIII, and FcRn and Design of IgG1 Variants with Improved Binding to the FcγRJournal of Biological Chemistry, 2001
- Rituximab (anti-CD20 monoclonal antibody) as single first-line therapy for patients with follicular lymphoma with a low tumor burden: clinical and molecular evaluationBlood, 2001
- A novel PCR-based method for direct Fcγ receptor IIIa (CD16) allotypingJournal of Immunological Methods, 2000
- Rituximab (Anti‐CD20) Therapy of B‐Cell Lymphomas: Direct Complement Killing is Superior to Cellular Effector MechanismsScandinavian Journal of Immunology, 2000
- Immunoglobulin G Fc-receptor (FcγR) IIA and IIIB polymorphisms related to disability in MSNeurology, 1999
- A novel polymorphism of FcgammaRIIIa (CD16) alters receptor function and predisposes to autoimmune disease.Journal of Clinical Investigation, 1997
- Rapid detection of theJournal of Immunological Methods, 1996
- Differential In Vitro and In Vivo Antitumor Effects Mediated by Anti-CD40 and Anti-CD20 Monoclonal Antibodies Against Human B-Cell LymphomasJournal of Immunotherapy, 1996
- Human Fc gamma RIII: cloning, expression, and identification of the chromosomal locus of two Fc receptors for IgG.Proceedings of the National Academy of Sciences, 1989
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958